Year of Award

2022

Document Type

Thesis

Degree Type

Master of Science (MS)

Degree Name

Cellular, Molecular and Microbial Biology

Other Degree Name/Area of Focus

Immunology emphasis

Department or School/College

Division of Biological Sciences

Committee Chair

Jay Evans

Commitee Members

Scott Wetzel, Erica Woodahl

Keywords

influenza, adjuvants, vaccines, TLR7/8, TLR4

Publisher

University of Montana

Subject Categories

Immunity | Influenza Virus Vaccines

Abstract

Influenza virus infection is a global health concern resulting in death and illness each year, which disproportionally effects high-risk individuals. While there are several approved vaccines for seasonal influenza, there are some limitations to consider: current vaccines provide minimal cross protection against seasonally drifted influenza subtypes, influenza vaccine strains change each year, requiring timely manufacture of a new vaccine. Thus, vaccines capable of inducing a more robust and broadly protective immune response to multiple influenza subtypes remains a critical unmet need. Adjuvants and novel delivery systems are an interesting and promising avenue of exploration for enhancing and broadening seasonal influenza vaccine effectiveness. Here we describe a combination TLR4 and TLR7/8 adjuvant liposome delivery system. When combined with a detergent-split influenza vaccine, our combination adjuvant delivery system enhanced influenza-specific humoral and cell-mediated immune responses in mice and mini-pigs. Additionally, the combination adjuvant system demonstrates a unique and synergistic immune response in human peripheral blood mononuclear cells (PBMCs). These adjuvants, when delivered together in an influenza vaccine, provided protection from heterologous (seasonally drifted) influenza challenge.

Download

Share

COinS
 

© Copyright 2022 Shelby Lynn Cole